Orion Oyj
Develops, manufactures, and markets human and veterinary pharmaceuticals and APIs.
ORNAV | HE
Overview
Corporate Details
- ISIN(s):
- FI0009014377 (+1 more)
- LEI:
- 74370029VAHCXDR7B745
- Country:
- Finland
- Address:
- Orionintie 1, FI-02200 ESPOO
- Website:
- https://www.orion.fi/en/
- Sector:
- Manufacturing
Description
Orion Oyj is a globally operating pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals, as well as active pharmaceutical ingredients (APIs). The company's portfolio encompasses a wide range of products, including prescription drugs, generic medications, and over-the-counter (OTC) products. In addition to its proprietary and generic product lines for both human and animal health, Orion provides contract manufacturing and packaging services to other pharmaceutical entities. The company manages the entire pharmaceutical value chain, from research and development through to production and marketing.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2008-02-25 11:00 |
ORION OYJ: GTx ANNOUNCED PHASE III CLINICAL DATA FOR TOREMIFENE
CITRATE 80 mg
|
English | HTML • 2.2 KB | ||
| 2008-02-25 11:00 |
ORION OYJ: GTx JULKAISI FAASI III KLIINISIÄ TULOKSIA 80 mg
TOREMIFEENISITRAATIS…
|
Finnish | HTML • 2.3 KB | ||
| 2008-02-07 21:38 |
Matters to be handled at Orion's AGM on 25 March 2008
|
English | HTML • 9.3 KB | ||
| 2008-02-07 21:38 |
Orion Oyj:n varsinaisessa yhtiökokouksessa 25.3.2008 käsiteltävät
asiat
|
Finnish | HTML • 8.6 KB | ||
| 2008-02-07 06:32 |
Orion-konsernin tilinpäätöstiedote vuodelta 2007
|
Finnish | PDF • 158.5 KB | ||
| 2008-02-07 06:31 |
Orion Group Financial Review of 2007
|
English | PDF • 162.3 KB | ||
| 2008-01-28 08:30 |
98,020 Orion A-shares converted into B-shares
|
English | HTML • 809 bytes | ||
| 2008-01-28 08:30 |
98.020 Orionin A-osaketta muunnettu B-osakkeiksi
|
Finnish | HTML • 725 bytes | ||
| 2008-01-24 13:01 |
Positive primary endpoint from FIRST-STEP study with Stalevo in early
Parkinson…
|
English | HTML • 2.8 KB | ||
| 2008-01-24 13:01 |
Positiivinen tulos Parkinson-lääke Stalevolla tehdyn
FIRST-STEP-tutkimuksen pää…
|
Finnish | HTML • 3.0 KB | ||
| 2007-11-27 16:21 |
Announcement by Orion Corporation in accordance with section 10 of
chapter 2 o…
|
English | HTML • 2.4 KB | ||
| 2007-11-27 16:21 |
Orion Oyj:n Arvopaperimarkkinalain 2 luvun 10 §:n mukainen ilmoitus
|
Finnish | HTML • 2.5 KB | ||
| 2007-11-15 11:01 |
Nimityksiä Orion-konsernin johtoryhmään alkaen 1.1.2008
|
Finnish | HTML • 1.6 KB | ||
| 2007-11-15 11:01 |
Appointments into Orion s Executive Management Board as of 1 January
2008
|
English | HTML • 1.8 KB | ||
| 2007-11-13 17:38 |
Orion sues Sun Pharmaceuticals in the U.S. to enforce a patent for
Stalevo®
|
English | HTML • 3.1 KB |
Automate Your Workflow. Get a real-time feed of all Orion Oyj filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Orion Oyj
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Orion Oyj via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
